TORONTO, Dec. 20, 2012 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") is pleased to announce that under a Letter of Intent concluded on December 19th, 2012, Biosign and West Champlain Healthy Community Corporation("WCHCC") have agreed to jointly launch several initiatives in 2013. WCHCC & Biosign will conduct a consumer marketability and user experience study for the Pulsewave™ Personal Health Monitor, a new product bundle from Biosign that will include a tablet PC, a Pulsewave™ PAD device and rich content applications that enhance health & wellness. If the trial is successful, WCHCC will then make Biosign Pulsewave™ consumer products available to their clients at a time-limited promotional price to be agreed by the parties. In addition, Biosign will conduct a public user-experience trial for the new Biosign Healthanywhere™ Kiosk on the premises of WCHCC. During this trial, one or more models of the Kiosk will be installed and WCHCC clients who use the Kiosk (with guidance from a WCHCC staff member) will be asked to record their responses via a survey. WCHCC then intends to install one or more production-model Biosign Kiosks for the continued use of staff and clients. Lastly, during 2013 WCHCC has agreed to work with Biosign to complete one or more clinical validation trials for new products that are currently being prepared for regulatory approval, including a new Average Breathing Rate measurement and the previously announced screening tool for Arrhythmias.
Biosign's CEO Mr. Robert Kaul stated: "We are very pleased to join forces with West Champlain Healthy Community Corporation. We fully support their mission, which is to enhance the health status of West Champlain residents, providing the best available healthcare technology to the people of the Ottawa Valley. Our goal is to provide WCHCC with a suite of products that meets the needs of their clients."
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides automated, computer enabled health information products. Key applications include the noninvasive monitoring of vital signs including blood pressure, pulse rate and breathing rate, enhanced with web services. The Company's Pulsewave™ medical device technology powers data collection for clinical decision support, self-care, wellness and disease management, while it's Healthanywhere™ software suite offers industry-leading remote patient monitoring solutions. For more information on Biosign, please visit www.biosign.com
About West Champlain Healthy Community Corporation.
WCHCC is a non-profit charitable organization based in Pembroke ON that owns and operates the Ottawa Valley Health Center on the grounds of the Pembroke Regional Hospital. The Health Center combines a full primary care medical practice with a number of important health and wellness programs including chronic disease clinics, dietary education services and even a yoga studio.
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in, Biosign's filings with Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Biosign Technologies Inc.
For further information:
Robert Kaul, CEO
Biosign Technologies Inc.
Phone: (416) 218-9800 ext. 201
Email: [email protected]
Jeffrey Weatherill, Executive Director
West Champlain Healthy Community Corporation
Phone: (613) 281-6704
Email: [email protected]